Evidence map›Paper›PMID 42178764›Full record

ArticleEmerging microbes & infections2026

Hantavirus seroprevalence and associated factors for exposure in south-central Uganda.

Gerald Katushabe, Victor Ssempijja, Deepashri Rao, Josephine Nalwadda, Kyle Rosenke, Steven J Reynolds, Jonah Omooja, Irene Andia Biraro, Mary K Grabowski, Evan A Mihalakakos and 5 more

Abstract read
In one paragraph

Article in Emerging microbes & infections, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Gerald KatushabeLaboratory of Virology, NIAID/NIH International Centers for Excellence in Research, UVRI, Entebbe, Uganda.
Victor SsempijjaClinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Deepashri RaoLaboratory of Virology, NIAID/NIH International Centers for Excellence in Research, UVRI, Entebbe, Uganda.ORCID 0000-0002-1950-962X
Josephine NalwaddaLaboratory of Virology, NIAID/NIH International Centers for Excellence in Research, UVRI, Entebbe, Uganda.
Kyle RosenkeLaboratory of Virology, Division of Intramural Research, NIAID/NIH, Rocky Mountain Laboratories, Hamilton, MT, USA.
Steven J ReynoldsLaboratory of Virology, NIAID/NIH International Centers for Excellence in Research, UVRI, Entebbe, Uganda.
Jonah OmoojaLaboratory of Virology, NIAID/NIH International Centers for Excellence in Research, UVRI, Entebbe, Uganda.
Irene Andia BiraroDepartment of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Mary K GrabowskiLaboratory of Virology, NIAID/NIH International Centers for Excellence in Research, UVRI, Entebbe, Uganda.
Evan A MihalakakosLaboratory of Virology, Division of Intramural Research, NIAID/NIH, Rocky Mountain Laboratories, Hamilton, MT, USA.
Ronald M GaliwangoRakai Health Sciences Program, Kalisizo, Uganda.
Robert SsekubuguRakai Health Sciences Program, Kalisizo, Uganda.
Denis K ByarugabaLaboratory of Virology, NIAID/NIH International Centers for Excellence in Research, UVRI, Entebbe, Uganda.
Heinz FeldmannLaboratory of Virology, Division of Intramural Research, NIAID/NIH, Rocky Mountain Laboratories, Hamilton, MT, USA.ORCID 0000-0001-9448-8227
David W HawmanLaboratory of Virology, Division of Intramural Research, NIAID/NIH, Rocky Mountain Laboratories, Hamilton, MT, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Orthohantaviruses are largely rodent-borne pathogens that can cause haemorrhagic fever with renal syndrome and hantavirus cardiopulmonary syndrome. In Uganda, the risk of human exposure is heightened by known rodent hosts, close human-rodent interaction in rural areas, and poor housing conditions. Despite this risk, data on human exposure remain scarce. This study sought to ascertain the seroprevalence of orthohantavirus exposure and identify associated factors with exposure among residents of the greater Masaka-Rakai region in Uganda. Seropositivity was assessed for orthohantavirus-specific IgG antibodies using commercial enzyme-linked immunosorbent assays. Logistic regression models were used to identify factors associated with seropositivity. Among 1,199 sera samples, orthohantavirus population-weighted seroprevalence was 7.4% (95% CI: 3.91-10.80). Males had a higher seroprevalence, while higher socioeconomic status was associated with a reduced burden of exposure to orthohantavirus. This study reports evidence of orthohantavirus exposure in Uganda, highlighting a previously underrecognized zoonotic risk in the region likely driven by close contact with rodent reservoirs and poor living conditions. The higher burden among males and lower-burden association with higher socioeconomic status, highlights the need for improved housing, rodent control, and integration of orthohantavirus surveillance into national public health programmes.

Indexed as

Antibodies, ViralHantavirus InfectionsOrthohantavirusAdolescentAdultAgedAnimalsChildChild, PreschoolFemaleHumansImmunoglobulin GMaleMiddle AgedRisk FactorsRodentiaAntibodies, ViralImmunoglobulin GAfricaantibodiesOrthohantavirusrodentsseroprevalenceUganda

Identifiers

PMID42178764
PMCPMC13202653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.